FDA — authorised 31 March 1954
- Application: NDA009190
- Marketing authorisation holder: GUERBET
- Local brand name: LIPIODOL
- Indication: OIL — INTRALYMPHATIC, INTRAUTERINE
- Status: approved
🇺🇸 Ultra-fluid lipiodol in United States
FDA authorised Ultra-fluid lipiodol on 31 March 1954
Marketing authorisation
Frequently asked questions
Is Ultra-fluid lipiodol approved in United States?
Yes. FDA authorised it on 31 March 1954.
Who is the marketing authorisation holder for Ultra-fluid lipiodol in United States?
GUERBET holds the US marketing authorisation.